Research not keeping up with bacteria

Jan 21, 2008

Harmful bacteria are evolving faster than scientists can develop antibiotics to fight them, U.S. researchers say.

Over-prescription of antibiotics, interbreeding of strains in the fertile environment of hospitals and use of the drugs in the production of livestock are all leading to resistant strains of bacteria, and the pipeline for new antibiotics has nearly run dry, The San Francisco Chronicle reported Sunday.

Only five new antibiotics have been approved in the last five years, compared to the early 1980's when 16 new treatments were in development, the newspaper said. The drop-off is mainly because drug companies are dropping out of the market, in favor of more lucrative drugs that must be taken for years or decades.

The lack of effective drugs is taking a toll, the Chronicle reported. About 99,000 Americans die each year from bacterial infections acquired in hospitals, and powerful strains like MRSA have made their way out of institutions and into the public at large -- most recently seen in a spate of outbreaks at schools.

To fix the problem, some experts -- like Dr. Louis Rice at Case Western Reserve University in Cleveland -- have proposed taxing drug companies that do not work on antibiotics to support research at companies that do.

Copyright 2008 by United Press International

Explore further: 'Ebola will return', veteran scientist warns

Related Stories

Q&A: Why are antibiotics used in livestock?

May 22, 2015

Wal-Mart, the world's biggest retailer, is the latest company to ask its suppliers to curb the use of antibiotics in farm animals. Here's a rundown of what's driving the decision: ...

Recommended for you

'Ebola will return', veteran scientist warns

33 minutes ago

Congolese expert Jean-Jacques Muyembe may be little known to the public, but he has been one of the world's top Ebola investigators since the first epidemic erupted in central Africa in 1976.

Score IDs patients with upper extremity DVT at low risk

15 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

May 29, 2015

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

May 29, 2015

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

bmcghie
not rated yet Jan 21, 2008
tax drug companies for NOT doing research in certain areas?! That's the stupidest idea I've ever heard! What is the next step after that one? Fine all the companies not doing research on cancer fighting drugs? On immunosuppressant drugs? On erectile difficulty drugs? On painkillers?
Please... somebody shut that man up. Drug companies go where the money is. Apparently, antibiotics are NOT where the money is. That's the price you pay for living in a capitalist country.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.